Obesity: A Disease Episode 85: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 1 of 3
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online.
In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care clinicians in the field of obesity medicine. Obesity Pillars can be found at https://www.journals.elsevier.com/obesity-pillars. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, please visit: www.obesitymedicine.org.
In this three part series, Dr. Bays and Dr. Bindlish review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors.
Episode Guests
Dr. Shagun Bindlish, MD Dr. Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC